立即登录 | 免费注册
全部学科 | 内科学 | 心血管病学 | 内分泌学与糖尿病 | 神经病学 | 消化病学 | 呼吸病学 | 肿瘤学 | 妇产科学 | 骨科学
疾病中心: 高血压 | 冠心病 | 心力衰竭 | 心律失常 | 脂肪性肝病 | 糖尿病 | 卒中 | 慢性阻塞性肺病 | 子宫内膜异位症 | 乳腺癌 | 肺癌 | 结直肠癌 | 器官移植
Loading
当前位置:期刊中心 > 爱思唯尔期刊精选全文 > 文摘导读
月经周期在成功妊娠子宫预处理中的作用
A role for menstruation in preconditioning the uterus for successful pregnancy
Jan J. Brosens MD PhD, Malcolm G. Parker PhD, Angus McIndoe MD PhD, Robert Pijnenborg PhD and Ivo A. Brosens MD PhD  |   2009/6/26 19:11:00 
American Journal of Obstetrics and Gynecology  |   2009   |   Volume 200 Issue 6   |   打印| 推荐给好友
上一篇: 对甾醇和甾体性激素神经保护作用的新见解:seladin-1/DHCR24范例
下一篇: 妇科肿瘤学中的腹腔内镜单孔道微创手术(LESS):技术与初步报告

Menstruation is widely viewed as serving no purpose other than to reinitiate the endometrial cycle in the absence of pregnancy. Yet, it is striking that cyclic endometrial decidualization followed by menstrual shedding is confined to the few species, including human beings, where placenta formation entails deep trophoblast invasion of maternal tissues and its vasculature. Both menstruation and pregnancy are inflammatory conditions that cause a degree of physiological ischemia-reperfusion tissue injury, albeit much more so in pregnancy. Thus, the emergence of cyclic menstruation may not have been an evolutionary coincidence but serves to protect uterine tissues from the profound hyperinflammation and oxidative stress associated with deep placentation, a process known as preconditioning. The concept of menstrual preconditioning provides a novel paradigm for understanding how reproductive disorders impact on pregnancy outcome. For example, endometriosis could be viewed as a disorder of exaggerated menstrual preconditioning that confers protection against placentation-related disorders, such as preeclampsia.

Key words: endometriosis; menstruation; preconditioning; preeclampsia; pregnancy

Article Outline

The link between menstruation and placentation
Uterine vascular remodeling in normal pregnancy and preeclampsia
Prepregnancy preparation for pregnancy
Menstrual preconditioning, endometriosis, and preeclampsia
Clinical Perspective
Further Reading
Appendix
References

Eutherian (placental) mammals have evolved different strategies to ensure reproductive success. The type of placenta and the depth of trophoblast invasion among various primate species appear to correlate with the extent of endometrial remodeling prior to conception and the occurrence of menstruation.1 For instance, strepsirrhine primates (lemurs and lorisiforms) have noninvasive epitheliochorial placentae and completely lack menstruation whereas simian primates (Old World monkeys, apes, and human beings) uniformly posses invasive hemochorial placentae and typically exhibit some form of menstruation, although there is considerable variation in the degree of blood loss.1 Compared with our primate relatives, menstruation in human beings is not only extraordinarily heavy but placentation is also exceptionally deep, with trophoblast invading not only the decidual endometrium but also the inner third of the myometrium, termed the “uterine junctional zone,” and its spiral arteries.[2] and [3]

Endometriosis is foremost a menstrual disorder, characterized by the presence of hormone-dependent ectopic endometrial implants, impaired differentiation of the eutopic endometrium, and thickening of the uterine junctional zone.[4] and [5] As endometriosis and preeclampsia are disorders at opposite ends of the reproductive process, there may be few reasons to suspect that both disease processes are interrelated. Yet, a recent case-control study reported that women with endometriosis-related infertility receiving in vitro fertilization treatment have a markedly reduced risk of developing preeclampsia or pregnancy-induced hypertension.6 Admittedly, the protective effect of endometriosis against preeclampsia or other obstetric disorders associated with impaired deep placentation–such as fetal growth restriction, placental abruption, and preterm labor–requires further validation in prospective studies. Nevertheless, these observations do raise questions regarding the role of cyclic endometrial remodeling and menstruation in determining subsequent pregnancy outcome.

The link between menstruation and placentation

Menstruation is defined by shedding of the superficial endometrial layer in response to decreasing progesterone levels accompanied by overt bleeding. Notably, uterine bleeding associated with ovulation or intercourse occurs in a variety of species but does not constitute menstrual bleeding. Apart from simian primates, true menstruation is found only in certain bat species, such as wild fulvous fruit bats, and perhaps the elephant shrew.[7] and [8] One unifying feature of the endometrium of menstruating species, including bats, appears to be the profound progesterone-driven remodeling of the stromal compartment, a process termed “decidualization” (Figure, A and B). This differentiation process is primarily defined by the transformation of stromal fibroblast into secretory epithelioid-like decidual cells and is further characterized by massive influx of specialized immune cells, especially uterine natural killer (uNK) cells, and vascular remodeling. Decidualization, however, also represents a tipping point, after which the integrity of the endometrium becomes inextricably dependent on elevated progesterone levels (Figure, C).[7] and [9] Thus, although all mammals with invasive placentae exhibit an endometrial decidual response on embryo implantation, only in menstruating species is this process directly under maternal control and occurs spontaneously during the late secretory phase of each cycle.



点击看大图  

FIGURE. Cyclic menstruation and deep placentation

A, Postovulatory increase in progesterone levels initiates endometrial differentiation in preparation to pregnancy. B, As is the case in other menstruating species, human endometrium exhibits spontaneous decidualization during late secretory phase of cycle, a process initiated around terminal spiral arteries (*) and characterized by epithelioid transformation of stromal fibroblasts (arrowheads). C, In absence of pregnancy, decreasing progesterone levels (P-) reverses decidual phenotype, induces expression of inflammatory cytokines and matrix metalloproteinases, and triggers menstrual shedding (visualized here by hysteroscopy), thereby allowing reinitiation of endometrial cycle. D, Persistently elevated progesterone levels (P+) in pregnancy promotes further decidualization of maternal tissues, essential for coordinated interstitial and endovascular trophoblast invasion. E, Physiologically transformed, large-capacity spiral artery in junctional zone myometrium. Muscularis of vessel is entirely replaced by a fibrinoid matrix with embedded trophoblast (arrowheads). F, Nontransformed junctional zone spiral artery in preeclamptic pregnancy, lacking endovascular trophoblast yet still surrounded by interstitial placental cells (arrowheads).

Brosens. A role for menstruation in preconditioning the uterus for successful pregnancy. Am J Obstet Gynecol 2009.


Menstruation is generally viewed as a nonadaptive consequence of uterine evolution, a concept first proposed by Finn.10 In other words, menstruation may have emerged as an inevitable consequence of the process of extensive endometrial remodeling necessary to accommodate deep hemochorial placentation but serves no other purpose except to reinitiate the endometrial cycle to allow a future pregnancy. Yet, it is striking that human reproduction has evolved in ways that limit the likelihood of pregnancy while maximizing the frequency of menstruation. For example, in comparison with many mammals with rapid reproductive turnover, ovulation in human beings and other primates occurs spontaneously rather than triggered by mating. Human beings also do not exhibit overt estrous behavior, have a limited and variable fertile window and concealed ovulation, lack embryonic diapause, and have a high incidence of preimplantation embryo wastage. Moreover, 90% of all menstrual cycles in very young adolescent girls are anovulatory.11

At first glance, the convergence of all these reproductive features in a single species, human beings, seems to be a pretty unfortunate evolutionary coincidence, accounting on the one hand for disappointingly low monthly fecundity rates (not, vert, similar 20%) and on the other for the high frequency of undesirable menstrual events. However, there are reasons to challenge this view of human reproduction as an evolutionary accident. In fact, the reciprocal relationship between fecundity and menstruation suggests that repeated menstrual priming or preconditioning of uterine tissues and its vasculature during nonconception cycles could be instrumental for successful deep placentation. This conjecture fits well with the observation that preeclampsia, a disorder characterized primarily by absence of spiral artery remodeling in the junctional zone myometrium,[3] and [12] is more prevalent and severe in a first pregnancy and especially so in young women. For example, data from the National Hospital Discharge Survey in the United States identified a maternal age < 20 years as the strongest risk factor for both preeclampsia and eclampsia.13 Conversely, it is well established that the risk of preeclampsia decreases sharply after the first full-term pregnancy and, albeit somewhat controversially, after a miscarriage.

Uterine vascular remodeling in normal pregnancy and preeclampsia

To answer the question of whether events in the menstrual cycle impact on pregnancy outcome, it is useful to first briefly revisit the uterine vascular changes associated with deep hemochorial placentation. Blood supply to a 50-g nonpregnant human uterus represents < 1% of the cardiac output. By the end of gestation, uterine perfusion has increased to 25% of cardiac output, 90% of which is carried through a limited number of physiologically transformed spiral arterioles into the intervillous space of the placenta. Thus, from a maternal perspective, pregnancy is an example of extraordinary rapid histogenesis, which is unrivalled in normal adult tissues.

Whether or not a placenta meets the fetal requirements for respiratory gas exchange and nutrient supply depends entirely on coordinated interstitial and endovascular invasion of the maternal decidua and junctional zone myometrium by extravillous cytotrophoblast (Figure, D and E). Endovascular invasion is preceded by interstitial trophoblast migration and is indispensable for the destruction of the arteriolar structure of the spiral arteries and the acquisition of a distended fibrofibrinoid vessel structure in these uterine zones.[14] and [15] Initially, this process is characterized by plugging of the terminal decidual vessels by endovascular trophoblast, thereby restricting the exposure of the early placenta and fetus to maternal arterial blood. Subsequently, the trophoblast plugs are dislocated, allowing perfusion of the placental intervillous space. This transition occurs toward the end of the first trimester and is thought to be associated with profound changes in the oxygen tension at the fetomaternal interface.16 The endovascular trophoblast continues to invade the spiral arteries, replaces the endothelial lining temporarily, and eliminates most of the musculoelastic tissue in the vessel. The morphological features of this process of physiological transformation of the spiral arteries have been extensively described elsewhere.[2], [14] and [17] Classically, 2 phases have been described: a deciduotrophoblast phase completed by 10 weeks gestation that involves remodeling of the endometrial portion of the spiral arteries and a myometriotrophoblast phase, from 14 weeks onward, encompassing the junctional zone portion of the vessels that critically reduces uterine blood flow resistance necessary for a reciprocal increase in placental perfusion.

Preeclampsia is increasingly attributed to shallow invasion of maternal tissues by extravillous cytotrophoblast.18 The term “shallow” trophoblast invasion is unfortunate for 2 reasons. First, it seems to imply that preeclampsia is primarily and/or commonly caused by defective cytotrophoblast differentiation and/or invasiveness, for which there is little or no direct evidence. Second, there is also no evidence of shallow invasion of the decidua or the decidual spiral arteries in preeclampsia. However, endovascular trophoblast invasion of the junctional zone portion of the spiral arteries is impaired, causing muscular and sometimes atherotic vessels to remain in this uterine zone (Figure, F).[3], [12] and [15] Although it has been reported that interstitial invasion of the junctional zone myometrium is more superficial in preeclampsia,19 this is, at least in our experience, far from an universal feature. The reason for impaired deep invasion of the junctional zone spiral arteries is unknown but may result from either an extreme maternal hyperinflammatory response to pregnancy,20 inadequate decidualization,[3] and [21] aberrant uNK cell function or impaired activation on trophoblast interaction,22 increased trophoblast cell death,19 or a combination of the above.23

Beyond doubt, however, is the fact that preeclampsia is a disease of early pregnancy. Uterine artery Doppler studies in the first trimester of pregnancy can reportedly identify at least 50% of patients who will subsequently develop preeclampsia.24 Combining Doppler studies with serum markers, such as placental protein 13, may improve prediction, especially of early-onset preeclampsia.[25] and [26] There is also considerable interest in the predictive value of circulating antiangiogenic factors, for example soluble fms-like tyrosine kinase and endoglin, although this approach may require serial measurements during the first and second trimesters of pregnancy.27

Prepregnancy preparation for pregnancy

Although endovascular trophoblast is indispensable for physiological transformation of the spiral arteries, it is important to note that maternal preparations start well before, and independently of, trophoblast invasion. During the late secretory phase of the cycle, decidualizing endometrial stromal cells form a cuff around the changing spiral arteries, characterized by endothelial swelling, vacuolation, and disorganization of the smooth muscle media.28 Biochemically, decidual cells play a decisive role in ensuring tissue hemostasis by expressing the fibrinolysis inhibitor plasminogen activator type 1 and tissue factor, a membrane-anchored glycoprotein that serves as the receptor for coagulation factor VII/VIIa.29 On secretory transformation, decidualizing endometrial cells also acquire the means to respond to trophoblast signals and to provide histotrophic support to the early conceptus.[30] and [31] Local production of chemokines such as CCL4, CXCL9, and CXCL10 triggers influx of specialized (CD56bright/CD16) uNK cells, which are a rich source of growth and angiogenic factors essential for vascular remodeling.[32] and [33] These cells are also capable of modulating T-cell function through expression of glycodelin A and galectin-1.34 In pregnancy, immunotolerance toward the conceptus is further achieved by increased activity of the indoleamine 2,3-dioxygenase, a tryptophan-catabolizing enzyme expressed in decidual cells and syncytiotrophoblast.35 Moreover, decidual cells are highly adapted to resist oxidative insults through a number of defense and repair mechanisms.[36] and [37] For instance, a variety of intracellular and extracellular free radical scavengers, such as superoxide dismutase 2, peroxiredoxin 2, thioredoxin, glutaredoxin, and glutathione peroxidase 3, are induced on decidualization. Differentiating stromal cells also express high levels of GADD45α, a factor involved in DNA repair and stress responses. Lastly, the proapoptotic forkhead transcription factor FOXO3a is no longer induced in decidual cells on oxidative stress, thereby preventing activation of the apoptosis machinery responsible for oxidative cell death in undifferentiated stromal cells.37

Taken together, uterine tissues acquire some unique features on decidualization that allow simultaneous protection of the conceptus against environmental or immunological insults and ensure hemostasis and tissue integrity during deep trophoblast invasion. Expression of a decidual phenotype is, however, strictly dependent on elevated progesterone levels. In the absence of pregnancy, decreasing progesterone levels not only reverse the decidual phenotype but also induce the expression of a gene network that encode for chemokines, proinflammatory cytokines, matrix metalloproteinases, and apoptotic factors, leading to influx of inflammatory cells, proteolytic breakdown of the extracellular matrix, cell death, focal bleeding, and menstruation.[7] and [38]

Menstrual preconditioning, endometriosis, and preeclampsia

Menstruation and pregnancy are both inflammatory events, albeit of very different magnitudes. In addition, both events are associated with variable degrees of uterine free radical production, oxidative stress, ischemia-reperfusion injury, vascular remodeling, and angiogenesis. Therefore, it seems not only plausible but likely that cyclic endometrial remodeling and menstruation precondition the human uterus for pregnancy. The term “preconditioning” refers to the paradoxical yet ubiquitous biological phenomenon that a brief exposure to a harmful stimulus at a dose below the threshold for tissue injury provides robust protection against, or tolerance to, the injurious effects of a subsequent more severe insult.[39] and [40] In recent years, the mechanisms underpinning preconditioning have been widely studied because of its therapeutic potential in preventing cardiac or cerebral injury in different clinical settings. Notably, reactive oxygen species production, activation of redox-sensitive signaling pathways, expression of angiogenic factors such as vascular endothelial cell growth factor, and resistance to cell death are major effectors in the process of preconditioning,40 all of which are highly regulated in the endometrium in response to hormonal signaling and perturbed in the presence of endometriosis.[41], [42], [43] and [44] Thus, it is tempting to speculate that endometriosis is primarily a disease of exaggerated endometrial preconditioning, which not only confers protection against hyperinflammation and oxidative stress associated with pregnancy but also endows endometrial cells with the mechanisms to survive in unfavorable ectopic locations.

To confer protection during pregnancy, cyclic uterine preconditioning must have prolonged and sustained effects that impact on the cellular responses in the basal endometrial layer, which contain the progenitor cells for the underlying junctional zone and superficial endometrium.45 Although direct proof of cyclic menstrual preconditioning is as yet lacking, it is striking that the junctional zone myometrium is significantly thicker on T2-weighted magnetic resonance imaging in patients with endometriosis when compared with age-matched control subjects.5 Power Doppler ultrasound studies have also shown that endometriosis is associated with increased endometrial-subendometrial blood flow during the late secretory phase of the cycle.46 In fact, the reciprocal correlation between the degree of uterine perfusion prior to pregnancy and the likelihood of obstetric complications may extend to other reproductive disorders, such as polycystic ovary syndrome and unexplained infertility (Appendix 1).

Perhaps the most compelling evidence for cyclic endometrial preconditioning comes from the observation that stromal cells purified from eutopic endometrial biopsy specimens from patients with and without endometriosis exhibit different responses to a decidualizing stimulus, even after prolonged culture.[47] and [48] Such sustained reprogramming of cellular responses likely involves epigenetic changes like DNA methylation or posttranslational histone tail modifications. This is indeed the case as illustrated by experiments in the baboon model for endometriosis. Kim et al49 demonstrated that induction of endometriosis and chronic inflammation in this model resulted in a gradual decrease in endometrial HOXA10 expression, a homeobox transcription factor involved in endometrial development. Importantly, this down-regulation was only significant 6-12 months after the induction of endometriosis, corresponded to increased methylation of the proximal promoter of the HOXA10 gene, and was associated with enhanced expression of decidual markers, such as insulin-like growth factor binding protein-1.49

Clinical Perspective

Human reproduction has evolved in a way that inextricably links cyclic menstruation to optimal pregnancy outcome. We propose that cyclic endometrial decidualization and menstrual shedding is an example of physiological preconditioning that prepares uterine tissue for the dramatic vascular remodeling, reactive oxygen species production, and hyperinflammation associated with deep hemochorial placentation. In analogy with other organ systems, modest cyclic inflammation and oxidative stress may have cumulative and sufficiently large effects on the uterine epigenome to trigger an adaptive protective response and to induce changes in uterine hormonal responses and perfusion conducive for pregnancy. Understanding if and how cyclic endometrial remodeling is coupled to pregnancy outcome is more than merely an academic exercise. First, it provides a new paradigm for understanding prevalent reproductive disorders, such as endometriosis, and their impact on pregnancy outcome. Second, it raises the real possibility of identifying those patients at risk of adverse pregnancy outcome prior to conception, on basis of uterine perfusion studies, epigenetic analysis, or endometrial gene expression profiling during the late secretory phase of the cycle. If correct, our preconditioning hypothesis may also lead to novel and perhaps simple strategies to prevent adverse pregnancy outcome in at-risk patients.

References

1 R.D. Martin, The evolution of human reproduction: a primatological perspective, Am J Phys Anthropol 50 (Suppl45) (2007), pp. 59–84. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (0)

2 I. Brosens, W.B. Robertson and H.G. Dixon, The physiological response of the vessels of the placental bed to normal pregnancy, J Pathol Bacteriol 93 (1967), pp. 569–579. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (195)

3 J.J. Brosens, R. Pijnenborg and I.A. Brosens, The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature, Am J Obstet Gynecol 187 (2002), pp. 1416–1423. Abstract | PDF (140 K) | View Record in Scopus | Cited By in Scopus (100)

4 R.O. Burney, S. Talbi and A.E. Hamilton et al., Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis, Endocrinology 148 (2007), pp. 3814–3826. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (28)

5 G. Kunz, M. Herbertz, D. Beil, P. Huppert and G. Leyendecker, Adenomyosis as a disorder of the early and late human reproductive period, Reprod Biomed Online 15 (2007), pp. 681–685. View Record in Scopus | Cited By in Scopus (5)

6 I.A. Brosens, P. De Sutter and T. Hamerlynck et al., Endometriosis is associated with a decreased risk of pre-eclampsia, Hum Reprod 22 (2007), pp. 1725–1729. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (5)

7 J.J. Brosens and B. Gellersen, Death or survival–progesterone-dependent cell fate decisions in the human endometrial stroma, J Mol Endocrinol 36 (2006), pp. 389–398. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (14)

8 X. Zhang, C. Zhu and H. Lin et al., Wild fulvous fruit bats (Rousettus leschenaulti) exhibit human-like menstrual cycle, Biol Reprod 77 (2007), pp. 358–364. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (1)

9 S. Labied, T. Kajihara and P.A. Madureira et al., Progestins regulate the expression and activity of the forkhead transcription factor FOXO1 in differentiating human endometrium, Mol Endocrinol 20 (2006), pp. 35–44. View Record in Scopus | Cited By in Scopus (20)

10 C.A. Finn, Menstruation: a nonadaptive consequence of uterine evolution, Q Rev Biol 73 (1998), pp. 163–173. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (19)

11 M.D. Wheeler, Physical changes of puberty, Endocrinol Metab Clin North Am 20 (1991), pp. 1–14. View Record in Scopus | Cited By in Scopus (31)

12 I.A. Brosens, W.B. Robertson and H.G. Dixon, The role of the spiral arteries in the pathogenesis of preeclampsia, Obstet Gynecol Annu 1 (1972), pp. 177–191. View Record in Scopus | Cited By in Scopus (296)

13 A.F. Saftlas, D.R. Olson, A.L. Franks, H.K. Atrash and R. Pokras, Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986, Am J Obstet Gynecol 163 (1990), pp. 460–465. View Record in Scopus | Cited By in Scopus (197)

14 R. Pijnenborg, J.M. Bland, W.B. Robertson and I. Brosens, Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy, Placenta 4 (1983), pp. 397–413. Abstract | PDF (7537 K) | View Record in Scopus | Cited By in Scopus (212)

15 R. Pijnenborg, L. Vercruysse and M. Hanssens, The uterine spiral arteries in human pregnancy: facts and controversies, Placenta 27 (2006), pp. 939–958. Article | PDF (970 K) | View Record in Scopus | Cited By in Scopus (73)

16 E. Jauniaux, A.L. Watson, J. Hempstock, Y.P. Bao, J.N. Skepper and G.J. Burton, Onset of maternal arterial blood flow and placental oxidative stress: a possible factor in human early pregnancy failure, Am J Pathol 157 (2000), pp. 2111–2122. View Record in Scopus | Cited By in Scopus (193)

17 R. Pijnenborg, G. Dixon, W.B. Robertson and I. Brosens, Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy, Placenta 1 (1980), pp. 3–19. Abstract | PDF (3183 K) | View Record in Scopus | Cited By in Scopus (243)

18 Y. Zhou, C.H. Damsky, K. Chiu, J.M. Roberts and S.J. Fisher, Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts, J Clin Invest 91 (1993), pp. 950–960. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (278)

19 M. Kadyrov, C. Schmitz, S. Black, P. Kaufmann and B. Huppertz, Pre-eclampsia and maternal anemia display reduced apoptosis and opposite invasive phenotypes of extravillous trophoblast, Placenta 24 (2003), pp. 540–548. Abstract | PDF (658 K) | View Record in Scopus | Cited By in Scopus (41)

20 C.W. Redman and I.L. Sargent, Latest advances in understanding preeclampsia, Science 308 (2005), pp. 1592–1594. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (311)

21 J.D. Aplin, Implantation, trophoblast differentiation and hemochorial placentation: mechanistic evidence in vivo and in vitro, J Cell Sci 99 (1991), pp. 681–692. View Record in Scopus | Cited By in Scopus (183)

22 S.E. Hiby, J.J. Walker and K.M. O'Shaughnessy et al., Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success, J Exp Med 200 (2004), pp. 957–965. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (204)

23 P. Kaufmann, S. Black and B. Huppertz, Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia, Biol Reprod 69 (2003), pp. 1–7. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (150)

24 W. Plasencia, N. Maiz, S. Bonino, C. Kaihura and K.H. Nicolaides, Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia, Ultrasound Obstet Gynecol 30 (2007), pp. 742–749. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (16)

25 K.H. Nicolaides, R. Bindra and O.M. Turan et al., A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound, Ultrasound Obstet Gynecol 27 (2006), pp. 13–17. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (42)

26 R. Romero, J.P. Kusanovic and N.G. Than et al., First-trimester maternal serum PP13 in the risk assessment for preeclampsia, Am J Obstet Gynecol 99 (2008), pp. 122.e1–122.e11.

27 O. Erez, R. Romero and J. Espinoza et al., The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age, J Matern Fetal Neonatal Med 21 (2008), pp. 279–287. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (4)

28 C.M. Craven, T. Morgan and K. Ward, Decidual spiral artery remodeling begins before cellular interaction with cytotrophoblasts, Placenta 19 (1998), pp. 241–252. Article | PDF (74303 K) | View Record in Scopus | Cited By in Scopus (69)

29 C.J. Lockwood, G. Krikun, R. Caze, M. Rahman, L.F. Buchwalder and F. Schatz, Decidual cell-expressed tissue factor in human pregnancy and its involvement in hemostasis and preeclampsia-related angiogenesis, Ann N Y Acad Sci 1127 (2008), pp. 67–72. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (1)

30 G.J. Burton, A.L. Watson, J. Hempstock, J.N. Skepper and E. Jauniaux, Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy, J Clin Endocrinol Metab 87 (2002), pp. 2954–2959. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (59)

31 A.P. Hess, A.E. Hamilton and S. Talbi et al., Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulators, Biol Reprod 76 (2007), pp. 102–117. View Record in Scopus | Cited By in Scopus (45)

32 J. Hanna, D. Goldman-Wohl and Y. Hamani et al., Decidual NK cells regulate key developmental processes at the human fetal-maternal interface, Nat Med 12 (2006), pp. 1065–1074. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (149)

33 C. Tayade, G.P. Black, Y. Fang and B.A. Croy, Differential gene expression in endometrium, endometrial lymphocytes, and trophoblasts during successful and abortive embryo implantation, J Immunol 176 (2006), pp. 148–156. View Record in Scopus | Cited By in Scopus (30)

34 L.A. Koopman, H.D. Kopcow and B. Rybalov et al., Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential, J Exp Med 198 (2003), pp. 1201–1212. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (176)

35 Y. Kudo, T. Hara and T. Katsuki et al., Mechanisms regulating the expression of indoleamine 2,3-dioxygenase during decidualization of human endometrium, Hum Reprod 19 (2004), pp. 1222–1230. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (15)

36 B. Gellersen, I.A. Brosens and J.J. Brosens, Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives, Semin Reprod Med 25 (2007), pp. 445–453. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (6)

37 T. Kajihara, M. Jones and L. Fusi et al., Differential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization, Mol Endocrinol 20 (2006), pp. 2444–2455. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (19)

38 H.N. Jabbour, R.W. Kelly, H.M. Fraser and H.O. Critchley, Endocrine regulation of menstruation, Endocr Rev 27 (2006), pp. 17–46. View Record in Scopus | Cited By in Scopus (59)

39 R.B. Jennings, C.E. Murry, C. Steenbergen Jr and K.A. Reimer, Development of cell injury in sustained acute ischemia, Circulation 82 (1990), pp. II2–II12.

40 H. Otani, Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities, Antioxid Redox Signal 10 (2008), pp. 207–247. View Record in Scopus | Cited By in Scopus (10)

41 A. Agarwal, S. Gupta, L. Sekhon and R. Shah, Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications, Antioxid Redox Signal 10 (2008), pp. 1375–1403. View Record in Scopus | Cited By in Scopus (3)

42 P.A. Fowler, J. Tattum and S. Bhattacharya et al., An investigation of the effects of endometriosis on the proteome of human eutopic endometrium: a heterogeneous tissue with a complex disease, Proteomics 7 (2007), pp. 130–142. View Record in Scopus | Cited By in Scopus (11)

43 S.H. Kao, H.C. Huang, R.H. Hsieh, S.C. Chen, M.C. Tsai and C.R. Tzeng, Oxidative damage and mitochondrial DNA mutations with endometriosis, Ann N Y Acad Sci 1042 (2005), pp. 186–194. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (4)

44 N. Sugino, The role of oxygen radical-mediated signaling pathways in endometrial function, Placenta 28 (SupplA) (2007), pp. S133–S136. Article | PDF (142 K) | View Record in Scopus | Cited By in Scopus (6)

45 J.J. Brosens, F.G. Barker and N.M. de Souza, Myometrial zonal differentiation and uterine junctional zone hyperplasia in the non-pregnant uterus, Hum Reprod Update 4 (1998), pp. 496–502. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (36)

46 P. Xavier, J. Beires, H. Barros and J. Martinez-de-Oliveira, Subendometrial and intraendometrial blood flow during the menstrual cycle in patients with endometriosis, Fertil Steril 84 (2005), pp. 52–59. Article | PDF (119 K) | View Record in Scopus | Cited By in Scopus (4)

47 P.A. Klemmt, J.G. Carver, S.H. Kennedy, P.R. Koninckx and H.J. Mardon, Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity, Fertil Steril 85 (2006), pp. 564–572. Article | PDF (519 K) | View Record in Scopus | Cited By in Scopus (11)

48 F. Minici, F. Tiberi and A. Tropea et al., Endometriosis and human infertility: a new investigation into the role of eutopic endometrium, Hum Reprod 23 (2008), pp. 530–537. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (1)

49 J.J. Kim, H.S. Taylor and Z. Lu et al., Altered expression of HOXA10 in endometriosis: potential role in decidualization, Mol Hum Reprod 13 (2007), pp. 323–332. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (17)

 

References

N.J. Raine-Fenning, B.K. Campbell, N.R. Kendall, J.S. Clewes and I.R. Johnson, Endometrial and subendometrial perfusion are impaired in women with unexplained subfertility, Hum Reprod 19 (2004), pp. 2605–2614. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (24)

Z. Pandian, S. Bhattacharya and A. Templeton, Review of unexplained infertility and obstetric outcome: a 10 year review, Hum Reprod 16 (2001), pp. 2593–2597. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (57)

S. Palomba, T. Russo and F. Orio Jr et al., Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome, Hum Reprod 21 (2006), pp. 457–465. View Record in Scopus | Cited By in Scopus (16)

C.M. Boomsma, M.J. Eijkemans, E.G. Hughes, G.H. Visser, B.C. Fauser and N.S. Macklon, A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome, Hum Reprod Update 12 (2006), pp. 673–683. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (45)

P. Xavier, J. Beires, H. Barros and J. Martinez-de-Oliveira, Subendometrial and intraendometrial blood flow during the menstrual cycle in patients with endometriosis, Fertil Steril 84 (2005), pp. 52–59. Article | PDF (119 K) | View Record in Scopus | Cited By in Scopus (4)

I.A. Brosens, P. De Sutter and T. Hamerlynck et al., Endometriosis is associated with a decreased risk of pre-eclampsia, Hum Reprod 22 (2007), pp. 1725–1729. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (5)

 

Appendix

 

Supplemental Table and References
Reproductive disorder (Sub-) endometrial perfusion Risk of preeclampsia
Unexplained infertility Decreased1 Increased2
Polycystic ovary syndrome Decreased3 Increased4
Endometriosis Increased5 Decreased6

Brosens. A role for menstruation in preconditioning the uterus for successful pregnancy. Am J Obstet Gynecol 2009.


 

Drs J.J. Brosens and Parker are supported by the Institute of Obstetrics and Gynecology Trust.

Cite this article as: Brosens JJ, Parker MG, McIndoe A, et al. A role for menstruation in preconditioning the uterus for successful pregnancy. Am J Obstet Gynecol 2009;200:615.e1-615.e6.


Corresponding Author Contact InformationReprints: Jan J. Brosens, MD, PhD, Institute of Reproductive and Developmental Biology, Imperial College London, Du Cane Rd, London W12 0NN, United Kingdom



请登录后发表评论,点击此处登录。

慢性心衰诊治:规范中求突破
黄峻
2012-2-1
南京医科大学第一附属医院
房颤治疗:手段渐趋丰富 新型治疗药物不断涌现 非药物治疗备受关注
马长生
2012-2-1
首都医科大学附属北京安贞医院
注重老年人群特征 优化管理

刘梅林
2012-2-1
北京大学第一医院老年内科

 

相关文章

关注糖尿病,聚焦GLP-1!案例征集大赛

时间:2011-3~~2011-11
由中国医师协会主办、礼来国际贸易(上海)有限公司协办、爱思唯尔国际出版集团承办的“精彩案例我分享——关注糖尿病•聚焦GLP-1”案例征集活动将于2011年3月~ 11月在全国范围隆重展开。

关注青光眼患者, 让世界更明亮!

时间:2011-4~~2011-12
《中华眼科杂志》发起,辉瑞制药资助,旨在交流青光眼治疗理念,分享国内抗青光眼药物固定联合治疗经验的病例交流活动.

聚焦哮喘和COPD联合制剂治疗

时间:2010-12~~2011-12
哮喘和慢性阻塞性肺疾病(COPD)是常见、多发的气道炎症性疾病,这类疾病严重影响患者的生活质量。我们特别组织了该类案例征集活动,奖品丰厚,快来参与!

中国选择 达标看我

时间:2011-9~~2012-9
本次活动对典型病例以分享的形式总结临床经验,通过跨专科、多层次的学术交流,对降压治疗方案、疗效进行解析与点评。